Really great news

I believe that this information will be of great news to many. Check this out:
MMRF CoMMunity Gateway Myeloma Expert Post: Read a
post from Dr. Craig Hofmeister from The Ohio State University about
"A Study to Evaluate 3 Dose Schedules of Daratumumab in
Participants With Smoldering Multiple Myeloma."

Read More

http://support.themmrf.org/site/R?i=KCCL562RNFp1U3HKW6Q8Sw